¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"annularis telangiectodes purpura"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • itching purpura
    °¡·Á¿òÀÚ(»ö)¹Ý
  • immune thrombocytopenic purpura
    ¸é¿ª¼ºÀúÇ÷¼ÒÆÇÀÚ(»ö)¹Ý
  • idiopathic thrombocytopenic purpura
    Ư¹ßÀúÇ÷¼ÒÆÇÀÚ»ö¹Ýº´
  • necrotic purpura
    ±«»çÀÚ»ö¹Ý
  • neonatal purpura
    ½Å»ý¾ÆÀÚ»ö¹Ý
  • orthostatic purpura
    ±â¸³ÀÚ»ö¹Ý
  • obstructive purpura
    Æó¼âÀÚ»ö¹Ý
  • palpable purpura
    ÃËÁöÀÚ»ö¹Ý
  • posttransfusion purpura
    ¼öÇ÷ÈÄÀÚ»ö¹Ý
  • psychogenic purpura
    Á¤½Å¼ºÀÚ»ö¹Ý
  • purpura
    ÀÚ»ö¹Ý, ÀÚ»ö¹Ýº´
  • purpura erythematosa
    È«¹ÝÀÚ»ö¹Ý
  • purpura simplex
    ´Ü¼øÀÚ»ö¹Ý
  • rheumatic purpura
    ·ù¸¶Æ¼½ºÀÚ»ö¹Ý
  • solar purpura
    Àϱ¤ÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • itching purpura
    °¡·Á¿îÀÚ»ö¹Ý
  • necrotic purpura
    ±«»çÀÚ»ö¹Ý
  • neonatal purpura
    ½Å»ý¾ÆÀÚ»ö¹Ý
  • obstructive purpura
    Æó¼âÀÚ»ö¹Ý
  • orthostatic purpura
    ±â¸³ÀÚ»ö¹Ý
  • purpura
    ÀÚ»ö¹Ý, ÀÚ»ö¹Ýº´
  • purpura erythematosa
    È«¹ÝÀÚ»ö¹Ý
  • palpable purpura
    ÃËÁöÀÚ»ö¹Ý
  • posttransfusion purpura
    ¼öÇ÷ÈÄÀÚ»ö¹Ý
  • psychogenic purpura
    Á¤½ÅÀÚ»ö¹Ý
  • rheumatic purpura
    ·ù¸¶Æ¼½ºÀÚ»ö¹Ýº´
  • scorbutic purpura
    ±«Ç÷º´ÀÚ»ö¹Ý
  • senile purpura
    ³ëÀÎÀÚ»ö¹Ý
  • simple purpura
    ´Ü¼øÀÚ»ö¹Ý
  • solar purpura
    Àϱ¤ÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • idiopathic thrombocytopenic purpura =ITP
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´.
  • idopathic thrombocytopenic purpura
    Ư¹ß¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹ÝÁõ
  • immunologic thrombocytopenic purpura
    ¸é¿ª¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹Ý
  • post transfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ(âÃúìý­í¹Úèñø)
  • posttransfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ.
  • posttransfusion purpura
    ¼ö¼úÈÄÀÚ¹Ý(â¢âúý­í¹Úè)
  • posttransfusion purpura=PTP
    ¼öÇ÷ÈÄ ÀÚ¹ÝÁõ
  • psychogenic purpura
    ½ÉÀμºÀÚ¹Ý
  • purpura
    ÀÚ¹Ý(í¹Úè)
  • purpura
    ÀÚ¹ÝÁõ
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõí¹Úè).
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõ í¹Úè)
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõí¹Úè)
  • purpura bullosa
    ´ë¼öÆ÷¼º(ÓÞâ©øÜàõ) ÀÚ¹Ý.
  • purpura bullosa
    ´ë¼öÆ÷¼º ÀÚ¹Ý(ÓÞâ©øÜàõ í¹Úè)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º Àڹݺ´(úìá³÷ùÞªÊõá´àõí¹ÚèÜ»)
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º Àڹݺ´(Ì´ËÛ̬?˧ËÛËÛËöËÑËÓ).
  • bullous purpura
    ¼öÆ÷¼º ÀÚ¹Ý
  • corticosteroid purpura
    ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵åÀÚ¹ÝÁõ.
  • drug-induced purpura
    ¾à¹° À¯¹ß ÀÚ¹Ý(º´)(í¹Úè
  • dysproteinemic purpura
    ÀÌ»ó ´Ü¹éÇ÷¼º ÀÚ¹Ý(º´)
  • easy bruising syndrome => purpura simplex
  • factitious purpura
    Àΰø ÀÚ¹Ý(º´)
  • flat purpura
    ÆíÆòÀÚ¹Ý
  • fulminant purpura<³ª> p. fulminans
    Àü°Ý¼º ÀÚ¹Ý(¡­í¹Úè).
  • gangrenous purpura
    ±«Àú¼º ÀÚ¹Ý(¡­í¹Úè)
  • hemorrhagic purpura
    ÃâÇ÷(¼º) ÀÚ¹Ý(º´)
  • henoch-schonlein purpura
    Çì³ëÈ£-½¦¶óÀÎ (Henoch-Schonlein) ÀÚ¹ÝÁõ
  • hypergammaglobulinemic purpura
    °ú°¨¸¶±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hyperglobulinemic purpura
    °ú±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TTP Thrombotic Thrombocytopenic Purpura
AITP autoimmune idiopathic thrombocytopenic purpura
ATP adenosine triphosphate; ambient temperature and pressure; autoimmune thrombocytopenic purpura
CPP cancer proneness phenotype; canine pancreatic polypeptide; cerebral perfusion pressure; chest pain p...
HGP hepatic glucose production; hyperglobulinemic purpura
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ITP Immune thrombocytopenic purpura
PTP Post transfusion purpura
SHP Scholein-Henoch purpura
TTP Thrombotic Thrombocytopenic Purpura
TTP-HUS Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • thrombasthenic purpura
    Ç÷¼ÒÆÇ Ãë¾à¼º Àڹݺ´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
anaphylactoid purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
autoimmune thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
Waldenstrom's purpura <haematology> A condition characterised by proliferation of cells resembling lymphocytes or plasma cells in the bone marrow, anaemia, increased sedimentation rate and hyperglobulinaemia. Physical findings include mucosal bleeding, skin purpura and enlargement of the lymph nodes, liver and spleen.
(27 Sep 1997)
Henoch-Schonlein purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
Henoch's purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
Schonlein's purpura <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
psychogenic purpura <syndrome> A condition, usually occurring in women, in which the individual bruises easily (purpura simplex) and the ecchymoses tend to enlarge and involve adjacent tissues, resulting in pain in the affected parts; so-called because similar lesions are produced by inoculation of the individual's blood or various components of red blood cells and it is thought to be a form of localised autosensitization, although no specific antibodies have been demonstrable; in some individuals, there seems to be a psychogenic mechanism.
Synonym: Gardner-Diamond syndrome, psychogenic purpura.
(05 Mar 2000)
purpura <clinical sign, dermatology> A small haemorrhage (up to about 1 cm in diameter) in the skin, mucous membrane or serosal surface, which may be caused by various factors, including blood disorders, vascular abnormalities and trauma.
Purpuric lesions may be associated with inflammation, in which case they present as papular purpura or the haemorrhage may not be accompanied by inflammation, in which case they are macular.
The term also comprises a group of haemorrhagic diseases characterised by the presence of purpuric lesions, ecchymoses and a tendency to bruise easily, which may be caused by decreased platelet counts, the presence of abnormal platelets, vascular defects or reactions to certain drugs.
(15 Dec 1997)
purpura, anaphylactoid See Purpura, Henoch-Schonlein.
(12 Dec 1998)
purpura angioneurotica An eruption marked by angioneurotic oedema, petechiae, and hyperesthesia of the skin and gastric mucous membrane.
(05 Mar 2000)
purpura fulminans A severe and rapidly fatal form of purpura haemorrhagica, occurring especially in children, with hypotension, fever, and disseminated intravascular coagulation, usually following an infectious illness.
(05 Mar 2000)
purpura haemorrhagica idiopathic thrombocytopenia purpura
purpura, henoch-schonlein HSP is a form of blood vessel inflammation, a vasculitis that affects small arterial vessels in the skin (capillaries) and the kidneys. Hsp results in skin rash associated with joint inflammation (arthritis) and cramping pain in the abdomen. Hsp frequently follows a bacterial or viral infection of the throat or breathing passages and is an unusual reaction of the body's immune system to this infection. Hsp occurs most commonly in children. Hsp is generally a mild illness that resolves spontaneously, but sometimes it can cause serious problems in the kidneys and bowels. Treatment is directed toward the most significant area of involvement. Joint pain can be relieved by antiinflammatory medications, such as aspirin or ibuprofen. Some patients can require cortisone-related medications, such as prednisone, especially those with significant abdominal pain or kidney disease. Also known as anaphylactoid purpura.
(12 Dec 1998)
purpura, hyperglobulinaemic Purpura associated with an increase in gamma-globulins. The condition is no longer considered a specific entity since the clinical and laboratory findings are observed in a variety of haematologic conditions.
(12 Dec 1998)
purpura iodica Iodic purpura, an eruption of discrete miliary petechiae, usually confined to the lower extremities, appearing in rare instances on administration of any of the iodides.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á